IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.270
0.00 (0.00%)
Aug 12, 2025, 8:00 PM - Market open
IGM Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 30.65 | 26.5 | 112.52 | 121.23 | 133.33 | 241.08 | Upgrade
|
| Short-Term Investments | 73.66 | 157.29 | 225.16 | 305.93 | 96.21 | 125.19 | Upgrade
|
| Cash & Short-Term Investments | 104.31 | 183.79 | 337.68 | 427.16 | 229.54 | 366.27 | Upgrade
|
| Cash Growth | -59.32% | -45.57% | -20.95% | 86.09% | -37.33% | 63.05% | Upgrade
|
| Other Receivables | 0.5 | 0.8 | 0.8 | 0.5 | - | - | Upgrade
|
| Receivables | 0.5 | 0.8 | 0.8 | 0.5 | - | - | Upgrade
|
| Prepaid Expenses | 2.18 | 8.87 | 8.53 | 10.07 | 10.5 | 7 | Upgrade
|
| Restricted Cash | - | 0.17 | 0.59 | 0.69 | 0.7 | - | Upgrade
|
| Total Current Assets | 106.99 | 193.62 | 347.6 | 438.42 | 240.75 | 373.27 | Upgrade
|
| Property, Plant & Equipment | - | 71.03 | 74.01 | 73.08 | 56.34 | 34.81 | Upgrade
|
| Other Long-Term Assets | - | 1.06 | 1.81 | 2 | 1.04 | 0.55 | Upgrade
|
| Total Assets | 106.99 | 265.71 | 423.41 | 513.5 | 298.13 | 408.63 | Upgrade
|
| Accounts Payable | 2.4 | 0.98 | 1.33 | 2.51 | 5.58 | 7.92 | Upgrade
|
| Accrued Expenses | 3.66 | 26.88 | 31.54 | 33.62 | 18.88 | 6.65 | Upgrade
|
| Current Portion of Leases | - | 7.12 | 5.83 | 5.82 | 3.32 | 2.67 | Upgrade
|
| Current Unearned Revenue | - | 2.65 | 3.78 | 2.74 | - | - | Upgrade
|
| Total Current Liabilities | 6.06 | 37.64 | 42.48 | 44.69 | 27.78 | 17.24 | Upgrade
|
| Long-Term Leases | - | 38.07 | 34.67 | 35.36 | 25.44 | 9.58 | Upgrade
|
| Long-Term Unearned Revenue | - | 141.47 | 143.02 | 146.2 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.37 | - | - | - | - | Upgrade
|
| Total Liabilities | 6.06 | 217.54 | 220.18 | 226.24 | 53.22 | 26.82 | Upgrade
|
| Common Stock | 0.6 | 0.6 | 0.59 | 0.43 | 0.33 | 0.32 | Upgrade
|
| Additional Paid-In Capital | 1,073 | 1,064 | 1,024 | 862.36 | 598.37 | 570.03 | Upgrade
|
| Retained Earnings | -972.35 | -1,017 | -821.24 | -574.83 | -353.72 | -188.56 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.16 | 0.15 | -0.7 | -0.07 | 0.03 | Upgrade
|
| Total Common Equity | 100.93 | 48.17 | 203.23 | 287.26 | 244.91 | 381.82 | Upgrade
|
| Shareholders' Equity | 100.93 | 48.17 | 203.23 | 287.26 | 244.91 | 381.82 | Upgrade
|
| Total Liabilities & Equity | 106.99 | 265.71 | 423.41 | 513.5 | 298.13 | 408.63 | Upgrade
|
| Total Debt | - | 45.19 | 40.51 | 41.17 | 28.76 | 12.24 | Upgrade
|
| Net Cash (Debt) | 104.31 | 138.6 | 297.17 | 385.99 | 200.78 | 354.03 | Upgrade
|
| Net Cash Growth | -51.93% | -53.36% | -23.01% | 92.24% | -43.29% | 68.66% | Upgrade
|
| Net Cash Per Share | 1.71 | 2.29 | 5.68 | 9.29 | 6.00 | 11.51 | Upgrade
|
| Filing Date Shares Outstanding | 60.29 | 59.78 | 58.79 | 43.18 | 32.51 | 32.01 | Upgrade
|
| Total Common Shares Outstanding | 60.19 | 59.65 | 58.68 | 43.08 | 32.5 | 31.97 | Upgrade
|
| Working Capital | 100.93 | 155.98 | 305.12 | 393.74 | 212.97 | 356.03 | Upgrade
|
| Book Value Per Share | 1.68 | 0.81 | 3.46 | 6.67 | 7.54 | 11.94 | Upgrade
|
| Tangible Book Value | 100.93 | 48.17 | 203.23 | 287.26 | 244.91 | 381.82 | Upgrade
|
| Tangible Book Value Per Share | 1.68 | 0.81 | 3.46 | 6.67 | 7.54 | 11.94 | Upgrade
|
| Machinery | - | 36.66 | 35.12 | 26.26 | 18.35 | 7.34 | Upgrade
|
| Construction In Progress | - | 1.01 | 5.8 | 5.11 | 2.53 | 17.93 | Upgrade
|
| Leasehold Improvements | - | 24.16 | 17.91 | 14.43 | 14.17 | 0.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.